Page last updated: 2024-09-05

phosphatidylcholines and bay-k-8644

phosphatidylcholines has been researched along with bay-k-8644 in 1 studies

Compound Research Comparison

Studies (phosphatidylcholines)	Trials (phosphatidylcholines)	Recent Studies (post-2010) (phosphatidylcholines)	Studies (bay-k-8644)	Trials (bay-k-8644)	Recent Studies (post-2010) (bay-k-8644)
32,204	443	5,593	2,555	0	144

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chander, A; Sen, N; Spitzer, AR; Wu, AM	1

Other Studies

1 other study(ies) available for phosphatidylcholines and bay-k-8644

Article	Year
Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells. Biochemical pharmacology, 1997, May-09, Volume: 53, Issue:9 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Dose-Response Relationship, Drug; Enzyme Activation; Nifedipine; Phosphatidylcholines; Protein Kinase C; Pulmonary Alveoli; Rats	1997

Article

Year

Activation of protein kinase C by 1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-py rid ine carboxylic acid methyl ester (Bay K 8644), a calcium channel agonist, in alveolar type II cells.

Biochemical pharmacology, 1997, May-09, Volume: 53, Issue:9

Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Agonists; Calcium Channels; Dose-Response Relationship, Drug; Enzyme Activation; Nifedipine; Phosphatidylcholines; Protein Kinase C; Pulmonary Alveoli; Rats

1997